Pancreatic Cancer Research

ResearcherShenyang Pharmaceutical UniversityActive in the last 2 years

Adili Tuersun

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0009-0002-5240-638X; OpenAlex author ID A5093494690.

Their work

Papers
3 (first author 3, last author 0)
Trials
0
Grants
0
Collaborators
2
Papers, trials and grants by year

2024: 2 papers · 2025: 1 paper

Papers 3

  1. Corrigendum to "Pancreatitis and Pancreatic Cancer Risk Among Patients With Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors: An Updated Meta-Analys… First author DOI 10.1016/j.clinthera.2024.11.010↗
  2. Pancreatitis and Pancreatic Cancer Risk Among Patients With Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors: An Updated Meta-Analysis of Randomized… First author DOI 10.1016/j.clinthera.2024.06.015↗
  3. Response to Letter Regarding Article, "Pancreatitis and Pancreatic Cancer Risk Among Patients with Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors:… First author DOI 10.1016/j.clinthera.2024.09.002↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Gang Cheng · 2 shared papers, 2024–2025
  2. Gang Cheng · 1 shared paper, 2024

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.